« Previous
Next »
Titles
- LA story: improving care management for chronically ill and chronically underserved : site visit report1
- Labeling for biosimilar products1
- Laboratory accreditation for analyses of foods: what you need to know about the FDA regulation : guidance for industry : small entity compliance guide1
- Laboratory safety: FDA should strengthen efforts to provide effective oversight : report to Congressional committees1
- Labs with questionably high billing for additional tests alongside COVID-19 tests warrant further scrutiny1
- Landscape of area-level deprivation measures and other approaches to account for social risk and social determinants of health in health care payments1
- Laser products: conformance with IEC 60825-1 Ed. 3 and IEC 60601-2-22 Ed. 3.1 : (Laser Notice No. 56) : guidance for industry and Food and Drug Administration staff1
- Limited population pathway for antibacterial and antifungal drugs1
- Linking state Medicaid data and birth certificates for maternal health research1
- Linking state health care data to inform policymaking: opportunities and challenges1
- Liposome drug products: chemistry, manufacturing, and controls : human pharmacokinetics and bioavailability : and labeling documentation1
- Listing of ingredients in tobacco products: (revised)1
- Live case presentations during investigational device exemption (IDE) clinical trials: guidance for institutional review boards, industry, clinical investigators, and Food and Drug administration staff1
- Logical observation identifiers names and codes for in vitro diagnostic tests: guidance for industry and Food and Drug Administration staff1
- Long COVID1
- Long term follow-up after administration of human gene therapy products1
- Long-term care: consumers, services, and financing : the basics1
- Long-term projections of health care spending and the implications for the federal budget: presentation at the 15th annual meeting of the OECD’s working party of parliamentary budget officials and independent fiscal institutions1
- Long-term trends of psychotropic drug use in nursing homes1
- Longer-term effects of the Better Care Reconciliation Act of 2017 on Medicaid spending1